Supreme Court Reserves Judgment in Patanjali's Misleading Advertisement Case

SC on Patanjali Case: Supreme Court reserved judgment against Patanjali Ayurved's promoter, yoga guru Ramdev, and managing director (MD) Balakrishna in a case concerning misleing vertisements of drugs me by company. court granted m three weeks to file an affidavit regarding steps taken to recall vertisements for medicines for which license has been revoked, exempting m from personal appearance for now.

Supreme Court also questioned president of Indian Medical Association (IMA), Dr. Asokan, for giving an interview to press on court's orders in case. court observed that Dr Asokan's actions mirrored those of Patanjali and expressed concern about example set for association's 3.5 lakh doctors.

Earlier, Patanjali's lawyers informed court that company published 322 apologies in newspapers over vertisements that me false claims about its products. court acknowledged a marked improvement in management's attitude and appreciated apologies carrying names of Ramdev and Balakrishna.

In previous hearings, court h questioned size of public apologies compared to company's vertisements and refused to accept ir apology, citing wilful disobedience. court ordered all district Ayurvedic and Unani officers in Haridwar since 2018 to submit actions taken by m.

contempt proceedings stem from publication of vertisements of products in violation of Drugs and Magic Remedies (Objectionable vertisements) Act, 1954 and its Rules, following a petition filed by Indian Medical Association (IMA). case has since expanded to include or FMCG companies exaggerating health benefits of ir products and role of doctors in promoting such goods.